
Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal…

Owkin is an AI biotech company focused on decoding complex biology to find the right treatment for every patient. Their core technology, Owkin K, is an agentic AI platform that integrates multimodal…
Founded: 2016
Headquarters / Footprint: French–American company with New York headquarters and multiple global offices
Tech focus: Multimodal, agentic biomedical AI (drug discovery, clinical development, diagnostics)
Reported total funding: $304.1M
Notable strategic investor/partner: Sanofi (strategic $180M investment)
Decoding complex biology to find the right treatment for every patient; accelerating drug discovery, development, and diagnostics using AI.
2016
Biotechnology Research
180000000
Strategic investment reported as $180M alongside a multi-year oncology collaboration
25000000
Reported $25M Series A extension (reported at the time to bring total to roughly $55M)
“Has raised institutional venture capital and strategic corporate investment (including a major strategic investment from Sanofi and participation from investors such as GV, Bpifrance, F-Prime, Cathay Innovation, Eight Roads, NJF Capital, Otium/Frst, Mubadala, MACSF)”
| Company |
|---|
About us
Owkin is an agentic AI company on a mission to explore complex biology to speed up and scale research for the creation of new treatments and diagnostics for patients. Owkin K, our AI co-pilot combines unparalleled access to multimodal data, cutting-edge AI to understand biology and pioneering agentic AI to achieve Biological Artificial Superintelligence in the future.
Owkin is comprised of a group of specialized companies that work seamlessly together, combining deep expertise with a shared mission to accelerate biological discovery. Owkin K is the technology foundation of our ecosystem, it provides cutting-edge co-pilots incorporating high-quality data infrastructure and AI tools to power breakthroughs for researchers, customers and our companies.
Owkin has raised over $300 million through investments from leading biopharma companies, including Sanofi and BMS, and venture funds like Fidelity, GV and Bpifrance, among others.Owkin is seeking the best and brightest to join our fast-growing and dynamic team.
Position is based in our Paris, Nantes or London offices or remotely in France, UK, Germany.
Please submit your CV in English
About the role:
We’re building AI agents that help researchers solve real problems in biology and drug discovery. As Senior Product Manager – Applied AI, you’ll lead the definition and delivery of agents and tools for K, our agentic copilot—from early discovery to clinical insights.
You’ll work with multi-disciplinary teams to identify high-impact use cases, frame the right product questions, and iterate on solutions. This role is critical to ensuring our AI agents and tools solve the right problems, in the right ways, for the right users.
You’ll need to be deeply user- and data-driven, with strong product strategy skills and the ability to balance scientific nuance with product clarity.
In particular, you will:
About you
What we offer
Recruitment Process & Security
If you think that you have been a victim of fraud,
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Check the identity of the talent team on LinkedIn.
Check the existence of the position on our website
https://owkin.com/hiring
Notify Owkin's recruitment unit at this address
hiring@owkin.com
contact the following authorities:
FR https://www.internet-signalement.gouv.fr/
UK https://www.actionfraud.police.uk/reporting-fraud-and-cyber-crime
US https://reportfraud.ftc.gov/